CompletedPHASE1, PHASE2NCT03308045
Evaluation of EYS606 in Patients With Non-infectious Posterior, Intermediate or Panuveitis
Studying Posterior uveitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Eyevensys
- Principal Investigator
- Antoine AB BREZIN, MD, MDHôpital Cochin - Paris - France
- Intervention
- pEYS606(biological)
- Enrollment
- 15 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2017 – 2021
Study locations (4)
- CHU de Grenoble - Hôpital Michallon, Grenoble, France
- Hôpital Cochin, Paris, France
- Bristol Eye Hospital, Bristol, United Kingdom
- Moorfields Eye Hospital, London, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03308045 on ClinicalTrials.gov